Cardiac Stem Cells From Heart Disease Patients May Be Harmful
Stem cell therapy has gained popularity as a treatment option for patients with severe and end-stage heart failure. However, researchers at Tel Aviv University caution against using cells from the host patient to repair tissue as this method may cause harm to patients. Their study is published the journal Circulation.
"We found that, contrary to popular belief, tissue stem cells derived from sick hearts do not contribute to heart healing after injury," said Prof. Jonathan Leor of TAU's Sackler Faculty of Medicine and Sheba Medical Center, who led the study. "Furthermore, we found that these cells are affected by the inflammatory environment and develop inflammatory properties. The affected stem cells may even exacerbate damage to the already diseased heart muscle."
Tissue or adult stem cells – "blank" cells that can act as a repair kit for the body by replacing damaged tissue – encourage the regeneration of blood vessel cells and new heart muscle tissue. But the TAU's study suggests that stem cells, like any drug, can have adverse effects. The findings indicate that stem cells used in cardiac therapy should be drawn from healthy donors or be better genetically engineered for the patient, Prof. Leor points out.
In addition, the TAU team also discovered the molecular pathway involved in the negative interaction between stem cells and the immune system as they isolated stem cells in mouse models of heart disease. After exploring the molecular pathway in mice, the researchers focused on cardiac stem cells in patients with heart disease.
The results could help improve the use of autologous stem cells – those drawn from the patients themselves – in cardiac therapy. "We showed that the deletion of the gene responsible for this pathway can restore the original therapeutic function of the cells," Prof. Leor said.
The researchers are currently testing a gene editing technique (CRISPER) to inhibit the gene responsible for the negative inflammatory properties of the cardiac stem cells of heart disease patients. "We hope our engineered stem cells will be resistant to the negative effects of the immune system," Prof. Leor added.
Source: American Friends of Tel Aviv University
Image Credit: Pixabay
Published on : Tue, 20 Jun 2017
The Connex® Spot Monitor features an easy-to-use, vivid touchscreen display and provides accurate vital signs measurement including blood pressure averaging, spot checking, interval monitoring and custom scoring across patient populations. The device...
Emergency monitor and defibrillator with touchscreen The DEFIGARD Touch 7 is an indispensable tool for rescuers. The device is extremely compact and offers the latest defibrillation technology in combination with comprehensive monitoring functions....
The Serie TEE is the first washer-disinfector specially designed for cardiac transesophageal probes . For efficiency of cardiology departments Safe and fully automated, this reliable and fast probe reprocessor offers a complete reprocessing...
Unbelievably small and light mechanical chest compression device In case of a sudden cardiac arrest, immediate chest compressions are required. Performing manual chest compressions well for an extended period of time is almost impossible. Thanks to...
Proven 6-channel ECG performance The most important cardiopulmonary function tests are combined in one single device: resting ECG and exercise ECG. Ready for networking with XML output.